相关实验视频

Updated: May 30, 2025

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

在乳腺癌中用于预后分层和个性化治疗的表观遗传学分析

Xiao Guo¹, Chuanbo Feng¹, Jiaying Xing¹

¹School of Pharmacy, Beihua University, Jilin, China.

Frontiers in immunology

|January 29, 2025

概括

一个新的机器学习衍生的表观遗传模型 (MLEM) 预测乳腺癌的预后. 它对个性化免疫疗法或化疗的患者进行了分层,改善了治疗策略.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物信息学是一种生物信息学.

背景情况:

乳腺癌发病率和异质性需要先进的预后工具.
表观遗传变化是乳腺癌进展和治疗反应的关键驱动因素.

研究的目的:

开发和验证一种机器学习模型,用于识别乳腺癌中预后表观遗传模式.
建立一种用于预测患者结果和指导个性化治疗的新工具.

主要方法:

机器学习衍生的表观遗传模型 (MLEM) 的构建,使用多队列的转录基因数据.
严格的机器学习技术用于模式识别.
跨独立数据集的验证和临床样本上的免疫组织化学.

主要成果:

MLEM准确地将患者分为高风险和低风险组.
低风险患者的预后更好,免疫透率增加,免疫治疗反应更好.
高风险患者的预后较差,但对化疗反应更好,克里斯被认为是一种潜在的治疗方法.

结论:

MLEM作为乳腺癌的强有力的预后工具.
该模型整合了表观遗传数据和机器学习,以加强临床决策.
MLEM有可能优化治疗策略,以改善患者的治疗结果.

关键词:

乳腺癌乳腺癌乳腺癌表观遗传学是指表观遗传学.机器学习是机器学习.个性化治疗是个性化的治疗.维克里斯蒂娜维克里斯蒂娜

更多相关视频

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...